Adjusted EBITDA from continuing operations of $1.2 million for the nine months ended September 30, 2025, compared to a loss of $0.1 million in the year ago period ...
Record Q4 and Full Year Revenue & PLOStrong Growth in Diluted EPS & Adjusted EBITDA AUSTIN, Texas, Nov. 13, 2025 (GLOBE NEWSWIRE) -- EZCORP, Inc. (NASDAQ: EZPW), a leading provider of pawn ...
Successfully began trading on NASDAQ under ticker TTRX on October 8, 2025 Strengthened its Board of Directors with the ...
Quarterly Labour Force Survey reports 248 000 more jobs created in Quarter 3 of 2025 1.2.1. Cabinet welcomed Statistics South Africa Quarterly Labour Force Survey reported 248 000 more jobs created in ...
Lantern Pharma will host a conference call and webcast to discuss third quarter 2025 financial results and business updates on Thursday, November 13, 2025 at 9:00 a.m. Eastern Time.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback